力生制药：副总经理郭晓燕拟减持不超0.0044%

Core Viewpoint - The company, Lisheng Pharmaceutical, announced that its Vice President, Guo Xiaoyan, holds 114,800 shares, accounting for 0.0446% of the total share capital, and plans to reduce holdings by up to 11,200 shares within three months after the announcement [1] Summary by Categories Shareholding Information - Guo Xiaoyan's current shareholding is 114,800 shares, which represents 0.0446% of the total share capital [1] - After excluding repurchased shares, the shareholding percentage is 0.0448% [1] Reduction Plan - The planned reduction involves selling up to 11,200 shares, which constitutes 0.0044% of the total share capital after excluding repurchased shares [1] - The shares to be sold are sourced from the 2022 restricted stock incentive plan [1]